February 6, 2020 / 8:05 AM / 20 days ago

BRIEF-Idorsia sees mix of equity hike, drug partnering among fundraising options

Feb 6 (Reuters) - Idorsia Ltd:

* CFO TELLS REUTERS EFFORTS TO RAISE NEW CASH COULD BE A COMBINATION OF "CLASSICAL EQUITY ROUTE," PARTNERING ON DRUGS

* CFO SAYS AIMS TO HAVE ENOUGH LIQUIDITY ON RESERVE TO COVER 12 MONTHS OF CASH BURN

* CEO SAYS "WE ARE DISCUSSING VERY BIG NUMBERS FOR PARTNERING"

* CEO SAYS PLANS TO FILE INSOMNIA DRUG WITH REGULATORS IN 2020, LAUNCH SEEN IN LATE 2021/EARLY 2022

* CEO SAYS FORCED TO RECRUIT PATIENTS OUTSIDE OF CHINA FOR TWO DRUG STUDIES DUE TO CORONAVIRUS DISRUPTION Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below